Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Adrenomedullin

EU orphan designation number: EU/3/10/744   
Active ingredient: Adrenomedullin
Indication: Treatment of acute lung injury
Sponsor: mondoBIOTECH Laboratories AG
Herrengasse 21, FL-9490 Vaduz, Liechtenstein

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Centralised Orphan - Designation EMEA/OD/139/09 (2010)3841 of 09/06/2010
29/09/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/139/09/T/01 (2011)7052 of 27/09/2011